Family Cohort Study on Primary Osteoporosis

计划入组 600 人 · 首次发布于 2023 年 3 月 23 日

Study of AK156 in Primary Osteoporosis Patients

计划入组 600 人 · 首次发布于 2012 年 1 月 31 日

Models of Primary Osteoporosis Screening in Male Veterans

计划入组 3,512 人 · 首次发布于 2019 年 9 月 6 日

Osteoporosis therapy(Ligand/AHP)

anti-osteoporosis agents (Biosolomon)

Primary sclerosing cholangitis(Engitix )

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

Southcoast Center For Primary & Specialty Care

United States

Meta-Analysis Confirms Epimedium's Efficacy in Primary Osteoporosis Treatment

GlycoNex Completes Patient Dosing in Phase 3 Trial of Denosumab Biosimilar SPD8 for Osteoporosis

FDA Accepts Bone Mineral Density as Primary Endpoint for Entera Bio's Oral Osteoporosis Drug Phase 3 Trial